AMPK inhibitor, compound C, inhibits coronavirus replication in vitro.
The coronavirus disease (COVID-19) pandemic has resulted in more than six million deaths by October 2022. Vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 are now available; however, more effective antiviral drugs are required for effective treatment. Here, we report that...
Main Authors: | Minsu Jang, Rackhyun Park, Ayane Yamamoto, Yea-In Park, Yeonjeong Park, Siyun Lee, Junsoo Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292309&type=printable |
Similar Items
-
AMPK inhibitor, compound C, inhibits coronavirus replication in vitro
by: Minsu Jang, et al.
Published: (2023-01-01) -
Compound C inhibits the replication of feline coronavirus
by: Yeonjeong Park, et al.
Published: (2024-03-01) -
Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model
by: Rackhyun Park, et al.
Published: (2021-12-01) -
Therapeutic Potential of EGCG, a Green Tea Polyphenol, for Treatment of Coronavirus Diseases
by: Junsoo Park, et al.
Published: (2021-03-01) -
Eupatin, a Flavonoid, Inhibits Coronavirus 3CL Protease and Replication
by: Yea-In Park, et al.
Published: (2023-05-01)